PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
53.86
ESG score 80-90% of AFMD's 61.89. Walter Schloss would scrutinize governance quality and regulatory exposure.
51.34
Environmental score 80-90% of AFMD's 58.09. Walter Schloss would scrutinize carbon exposure and transition planning.
52.89
Social score below 80% of AFMD's 66.39. Jim Chanos would check for potential social license and litigation risks.
57.36
Governance score 90-95% of AFMD's 61.19. Bill Ackman would demand clear governance improvement catalysts.